Navigation Links
DePuy ASR Lawsuit News: Rottenstein Law Group LLP Comments on Judge’s Decision to Exclude 2010 ASR Recall from Trial

(PRWEB) August 06, 2013

On July 26 U.S. District Judge David A. Katz granted a DePuy Orthopaedics motion to exclude evidence of the 2010 voluntary recall of the DePuy ASR during the September bellwether trial in the federal multidistrict litigation. The Rottenstein Law Group LLP, a DePuy ASR law firm, explains what this means for those who have filed or are looking to file DePuy lawsuits.

Katz granted the motion because of the Federal Rules of Civil Procedure, according to court documents in In re: DePuy Orthopaedics Inc., ASR Hip Implant Products Liability Litigation (MDL-2197; U.S District Court for the Northern District of Ohio). There are thousands of ASR metal-on-metal hip lawsuits pending in the federal consolidation.

“If the judge has decided to exclude evidence of the recall,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP, “then it’s probably because he feels that that evidence would be more prejudicial than probative. That is, if the jurors hear that the product at issue was recalled, they might conclude that there’s nothing else to consider and DePuy has to be culpable. But that’s not necessarily the proper legal analysis, and the judge has to ensure that the appropriate procedure of weighing all the relevant information isn’t short-circuited. Otherwise, DePuy will have grounds for an appeal of a verdict and award for the plaintiff. So the ruling might seem like a hurdle for the plaintiff, but it will likely make any decision in the plaintiff’s favor that much stronger.”

The DePuy ASR hip replacement system has been under U.S. Food and Drug Administration scrutiny, primarily because of one dangerous alleged side effect called “metal poisoning,” or “metallosis.” According to the FDA*, metal particles could peel off into the patient’s bloodstream when the device’s metal parts rub together. This could lead to potentially severe health problems.

The Rottenstein Law Group LLP represents clients in ASR hip lawsuits. The firm encourages those who believe they have suffered from the ASR’s alleged side effects to visit the firm’s website to download a free brochure to learn more about DePuy ASR settlements and lawsuits.


The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy Pinnacle Hip Lawsuit Filings in Federal Multidistrict Litigation Exceed 4,600, Bernstein Liebhard LLP Reports
2. DePuy Hip Class I Recall Announced By FDA of Its DePuy LPS Lower Extremity Dovetail Intercalary Hip Implant Component Due to Risk of Fracturing, Reports Wright & Schulte
3. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes DePuy Orthopaedic’s Motion for Summary Judgment in California Bellwether Case
4. DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal DePuy Pinnacle Hip Litigation
5. US Drug Watchdog Now Urges All DePuy ASR Recalled Metal Hip Implant Recipients In The Remaining States To Call Them Immediately If They Have Not Yet Been Identified
6. US Drug Watchdog Now Warns Recipients Of A Recalled DePuy ASR Hip Implant About Statute Of Limitations Deadline To Get Identified And Urges Recipients To Call Them
7. California Judge Allows Plaintiffs in DePuy ASR Litigation to Combine DePuy Pinnacle Claims, Parker Waichman LLP Notes
8. DePuy Hip Replacement Lawsuit News: California Judge Allows DePuy ASR Lawsuit Plaintiffs to Add Pinnacle Hip Claims
9. US Drug Watchdog Now Urges All DePuy Pinnacle Hip Implant Recipients To Call Them About A Vital Blood Test That Should Reveal A Premature Failure
10. US Drug Watchdog Now Urges All DePuy Pinnacle All Metal Hip Implant Recipients To Call Them For The Name Of A Special Blood Test That Will Determine A Premature Failure
11. US Drug Watchdog Now Urges All DePuy Pinnacle All Metal Hip Implant Recipients To Call Them About A Specific Blood Test Designed To Determine A Failure-Nationwide
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... of workshops to discuss bioavailability and the need to integrate dose form selection ... in collaboration with OBN, the membership organization supporting and bringing together the UK’s ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... PRMA Plastic ... November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , ... wake up every day excited to rebuild lives and it’s an honor to have ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film Studios brings Final ... ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, ... giving users limitless opportunities to stylize and create designs quickly and easily, all ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the ... to improve system efficiency and reliability. , The new Q-Suite 6 platform is based ... system avoids locking itself into a specific piece of software for many key components ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
Breaking Medicine Technology: